fbpx
Etnia Barcelona Moi Aussi

 Etnia Barcelona Presents Moi Aussi, an Artistic Project that Merges Art with the World of Optics

Etnia Barcelona presents Moi Aussi by Etnia Barcelona, a creative project driven by Andrea Zampol D’Ortia, optician and art lover, with the aim of becoming a global platform where artists from all over the world can express themselves and make their artistic careers known.

Etnia Barcelona Moi Aussi Abbazia Misericordia
Etnia Barcelona – Moi Aussi – Abbazia Misericordia

Since its beginnings more than 20 years ago, Etnia Barcelona has integrated art into its DNA, considering it as a way of understanding the world. This philosophy is reflected in all its campaigns and collaborations with artists. With Moi Aussi, the Barcelona eyewear brand combines art and optics by working closely with artists and highlighting its leitmotif “BEANARTIST”, which translates as “Rebel Through Art”.

In line with this philosophy and as a tribute to art and artists, the brand goes a step further with the acquisition of the Church Dell’Abbazia Della Misericordia in Venice, a historic space completely rebuilt in the thirteenth century, which will be renovated and fitted out to become the Moi Aussi Creative Laboratory, the place of work and stay of 24 international artists who will be part of the project each year. This laboratory will also be open to other established artists or artistic collectives who wish to exhibit their work in Venice.

MOI AUSSI, A PROJECT THAT TRANSCENDS BOUNDARIES

Moi Aussi is much more than a brand, it is an artistic project conceived as a creative movement that embraces artists from all over the world transcending any cultural border and ensuring that the true purpose of art triumphs over any diversity of culture, religion or ethnicity. Cultural diversity represents the strength of the Moi Aussi artistic community, the meaning of which reflects both the artists’ desire to be part of this community and the beginning of their journey, offering them artistic support and global visibility.

This project, aimed at an art world that is elevated, but also fresh, bold and young, is based on three fundamental pillars: art, emotion and contrast. Moi Aussi represents the artist’s manifesto, which in turn represents these three pillars and the declaration of intentions of this artistic movement.

The Moi Aussi logo is based on the verticality of the architectural elements of the Abbazia della Misericordia: pillars, columns and stained-glass windows. Thus, the purest geometric shapes match the poetry behind the project. This approach symbolizes the unique and distinctive personality of each artist, representing “MOI” as the soul of the artist and “AUSSI” as the sense of belonging to the artistic community, creating a balance between formality and creative expression.

THE CREATIVE LAB BY MOI AUSSI, A SPACE FOR ARTISTIC EXPLORATION

An art commission, formed by specialists from different disciplines of the art world, will be in charge of selecting the artists who will participate annually in this experience.

Each month, THE CREATIVE LAB will host two of these artists, who will live together and create five pieces of art from a pair of glasses frames. These will serve as a canvas for each one of them to create their own work of art with freedom and imagination.

Of these five pieces, one will remain in the Moi Aussi Gallery, another will be exhibited in the Etnia Barcelona museum, two works will be exhibited in art museums around the world and the last piece will be offered for sale through an auction.

All proceeds will be used for reinvestment and sustainability of the Moi Aussi project.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Featured Posts

Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight Announces 2024 Grant Winners

This year, 16 grants totaling almost $1 million USD have been awarded to 15 organizations for projects that will help eradicate uncorrected refractive error globally.

Learn More
Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

Read more
CooperVision

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

Read more
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Read more
SightGlass Vision

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight Announces 2024 Grant Winners

This year, 16 grants totaling almost $1 million USD have been awarded to 15 organizations for projects that will help eradicate uncorrected refractive error globally.

Learn More
Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

Read More
CooperVision

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

Read More
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Read More
SightGlass Vision

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Read More
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight Announces 2024 Grant Winners

This year, 16 grants totaling almost $1 million USD have been awarded to 15 organizations for projects that will help eradicate uncorrected refractive error globally.

Learn More
Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

Read more
CooperVision

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

Read more
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Read more
SightGlass Vision

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight Announces 2024 Grant Winners

This year, 16 grants totaling almost $1 million USD have been awarded to 15 organizations for projects that will help eradicate uncorrected refractive error globally.

Learn More
Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

Read more
CooperVision

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

Read more
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Read more
SightGlass Vision

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Read more